ASMB
Assembly Biosciences Inc
NASDAQ: ASMB · HEALTHCARE · BIOTECHNOLOGY
$26.95
+2.35% today
Updated 2026-04-30
Market cap
$442.93M
P/E ratio
—
P/S ratio
6.13x
EPS (TTM)
$-0.55
Dividend yield
—
52W range
$11 – $40
Volume
0.1M
Assembly Biosciences Inc (ASMB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.02M | $14.80M | $15.96M | $79.11M | $6.25M | $0.00 | $7.16M | $28.52M | $72.30M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | +64.1% | +7.8% | +395.6% | -92.1% | -100.0% | — | +298.2% | +153.5% |
| Cost of revenue | — | — | — | $0.00 | $0.00 | $0.00 | $23.96M | $64989.00 | $80251.00 | $44.23M | $72.74M | $85.76M | $101.34M | $466000.00 | $498000.00 | $48.90M | $129000.00 | $129000.00 |
| Gross profit | — | — | — | $0.00 | $0.00 | $0.00 | $-23.96M | $-64989.00 | $-80251.00 | $-35.21M | $-57.94M | $15.96M | $-22.23M | $6.25M | $-498000.00 | $-41.74M | $28.52M | $72.17M |
| Gross margin | — | — | — | — | — | — | — | — | — | -390.4% | -391.4% | 100.0% | -28.1% | 100.0% | — | -582.7% | 100.0% | 99.8% |
| R&D | $5.98M | $2.94M | $1.85M | $25.28M | $19.51M | $15.03M | $10.72M | $18.36M | $33.09M | $44.23M | $72.74M | $85.76M | $106.82M | $68.52M | $69.98M | $48.90M | $55.93M | $64.81M |
| SG&A | $1.19M | $397238.00 | $2.92M | $8.72M | $5.34M | $4.58M | $13.24M | $11.30M | $12.19M | $17.02M | $34.80M | $32.92M | $36.86M | $28.78M | $24.13M | $22.91M | $18.01M | $19.61M |
| Operating income | $-7.16M | $-3.34M | $-4.77M | $-34.00M | $-24.86M | $-19.60M | $-23.96M | $-29.66M | $-45.28M | $-52.23M | $-92.73M | $-102.71M | $-64.78M | $-132.69M | $-94.11M | $-64.65M | $-45.42M | $-12.12M |
| Operating margin | — | — | — | — | — | — | — | — | — | -579.1% | -626.4% | -643.4% | -81.9% | -2121.7% | — | -902.5% | -159.3% | -16.8% |
| EBITDA | $-7.16M | $-3.33M | $-13.23M | $-46.72M | $-24.79M | $-19.40M | $-23.95M | $-29.59M | $-44.80M | $-52.01M | $-92.73M | $-102.22M | $-58.40M | $-90.58M | $-93.62M | $-64.20M | $-45.29M | $-11.99M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | -576.7% | -626.4% | -640.3% | -73.8% | -1448.4% | — | -896.2% | -158.8% | -16.6% |
| EBIT | $-7.16M | $-3.34M | $-13.25M | $-46.73M | $-24.79M | $-19.40M | $-23.96M | $-29.66M | $-44.88M | $-52.23M | $-93.38M | $-102.71M | $-59.09M | $-91.05M | $-94.11M | $-64.65M | $-45.42M | $-12.12M |
| Interest expense | $1.64M | $1.20M | $10.53M | $116664.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.80M | $2.62M | $82.51M | $498000.00 | — | — | — |
| Income tax | $1.62M | $1.20M | $-10.52T | $342657.00 | $65066.00 | $201020.00 | $0.00 | $-1.20M | $-617672.00 | $-9.05M | $1.10M | $-774000.00 | $-2.62M | $-2.53M | $-1.02M | $33000.00 | $330000.00 | — |
| Effective tax rate | -22.6% | -35.9% | 100.0% | -1.0% | -0.3% | -1.0% | 0.0% | 4.1% | 1.4% | 17.5% | -1.2% | 0.8% | 4.1% | 1.9% | 1.1% | -0.1% | -0.8% | 0.0% |
| Net income | $-8.79M | $-4.54M | $-15.29M | $-34.34M | $-24.79M | $-19.40M | $-23.79M | $-28.45M | $-44.26M | $-42.81M | $-90.75M | $-97.63M | $-62.15M | $-129.85M | $-92.07M | $-61.23M | $-40.18M | $-6.12M |
| Net income growth (YoY) | — | +48.3% | -236.8% | -124.6% | +27.8% | +21.7% | -22.6% | -19.6% | -55.6% | +3.3% | -112.0% | -7.6% | +36.3% | -108.9% | +29.1% | +33.5% | +34.4% | +84.8% |
| Profit margin | — | — | — | — | — | — | — | — | — | -474.7% | -613.0% | -611.6% | -78.6% | -2076.4% | — | -854.8% | -140.9% | -8.5% |